cPRP Processing Set, Arthrex Angel System

Arthrex Angel System, cPRP-Verarbeitungsset

cPRP Processing Set, Arthrex Angel System

Finished Product

ABS-10063

Human

Angel-cPRP-System, mit Aspirationsset mit Antrieb (mit ACD-A)

Angel cPRP System with Aspiration Kit (w/ ACD-A)

ABS-10062T

BioSurge I System, 2.5 cc AlloSync Pure with Arthrex Angel cPRP and BMA Tray

BioSurge II System, 5.0 cc AlloSync Pure with Arthrex Angel cPRP and BMA Tray

BioSurge III System, 15 × 40 × 3 mm AlloSync DBM Cancellous Strip with Arthrex Angel cPRP and BMA Tray

BioSurge V System, 12 mm × 3 mm AlloSync Button Disc with Arthrex Angel cPRP and BMA Tray

Orthobiologics

Product

The Angel system is the only fully automated system that utilizes 3-sensor technology (3ST) and one-button automation to prepare customized platelet-rich plasma (PRP) formulations. The Angel system has the capability to deliver platelet concentrations up to 18x baseline with adjustable leukocyte concentrations. The Angel system utilizes the principle of flow cytometry, or light absorption by cells, to achieve precise separation with reproducible results. Platelet-rich plasma may be mixed with allograft and autograft bone prior to application to an orthopedic site.
<a href="https://angelapp.arthrex.com/" class="btn btn-outline-light mb-3">Angel System Calculator Web Application</a>

Angel® System

Child (D)

Spine

Procedure

The Angel cPRP and bone marrow processing system uses a proprietary platelet sensor and 1-button automation to deliver customized platelet-rich plasma (PRP) concentrate from bone marrow aspirate (BMA). Bone marrow is a rich source of platelets and nucleated progenitor cells. The Angel device is the only one to provide PRP concentrate from BMA with adjustable cellular levels.

Angel® cPRP and Bone Marrow Processing System

Knee

There has been a renewed interest in ACL primary repairs as the treatment for Sherman type I and type II ACL ruptures. Careful analysis of historical data has revealed that certain ACL tear subgroups, especially proximal tears with good tissue quality, have positive clinical outcomes with primary ACL repair.1
 
Studies reporting outcomes of remnant-preserving ACL surgeries have shown encouraging results and a greater potential for early healing and better functional outcomes compared with remnant-resecting surgeries.2 Preservation of the native ACL using the primary repair technique can achieve short-term clinical success and result in good clinical outcomes at 3-year follow-up in this carefully selected patient population.3
 
Arthroscopic primary repair is minimally invasive because no grafts need to be harvested, no graft tunnels or sockets need to be drilled, and revision surgery, if necessary, is more analogous to primary reconstructions.4 The goal of the procedure is to preserve the remnant native ligament. By doing this, the native nerve endings and blood supply are preserved.5
References
1. van der List JP, DiFelice GS. Role of tear location on outcomes of open primary repair of the anterior cruciate ligament: a systematic review of historical studies. Knee. 2017;24(5):898-908. doi:10.1016/j.knee.2017.05.009
2. van der List JP, DiFelice GS. Successful arthroscopic primary repair of a chronic anterior cruciate ligament tear 11 years following injury. HSS J. 2017;13(1):90-95. doi:10.1007/s11420-016-9530-8
3. Jonkergouw A, van der List JP, DiFelice GS. Arthroscopic primary repair of proximal anterior cruciate ligament tears: outcomes of the first 56 consecutive patients and the role of additional internal bracing. Knee Surg Sports Traumatol Arthrosc. 2019;27(1):21-28. doi:10.1007/s00167-018-5338-z
4. DiFelice GS, Villegas C, Taylor S. Anterior cruciate ligament preservation: early results of a novel arthroscopic technique for suture anchor primary anterior cruciate ligament repair. Arthroscopy. 2015;31(11):2162-2171. doi:10.1016/j.arthro.2015.08.010
5. DiFelice GS, van der List JP. Arthroscopic primary repair of proximal anterior cruciate ligament tears. Arthrosc Tech. 2016;5(5):e1057-e1061. doi:10.1016/j.eats.2016.05.009

ACL Repair

The BioACL technique harnesses the power of next-generation biologics to provide the ultimate anatomic, minimally invasive, reproducible approach for taking patient outcomes to the next level.
By prefilling ACL bone tunnels with a powerful composite of concentrated platelet-rich plasma (cPRP) from bone marrow aspirate (BMA) or whole blood processed with the Angel® system, the patient’s own bone collected with the GraftNet™ device, and AlloSync® Pure demineralized bone matrix, the BioACL technique provides all the necessary healing components for an ACL reconstruction procedure.
In conjunction with the QuadLink™ with InternalBrace™ technique, the BioACL technique has been shown to result in earlier range of motion, improved limb symmetry, less bone-tunnel widening, and improved patient-reported outcomes as compared to nonaugmented ACL procedures.1&nbsp;
 
 
Reference
1. Lavender CD, Schaver AL, Taylor S, et al. Anterior cruciate ligament reconstruction augmentation with bone marrow aspirate concentrate, demineralized bone matrix, and suture tape shows no difference in outcomes—but faster functional recovery—versus non-augmented anterior cruciate ligament reconstruction. Arthroscopy. Published online July 22, 2024.&nbsp;<a href="https://doi.org/10.1016/j.arthro.2024.06.042">https://doi.org/10.1016/j.arthro.2024.06.042</a>
 
The&nbsp;InternalBrace surgical technique is intended only to augment the primary repair/reconstruction by expanding the area of tissue approximation during the healing period and is not intended as a replacement for the native ligament. The&nbsp;InternalBrace technique is for use during soft tissue-to-bone fixation procedures and is not cleared for bone-to-bone fixation.

BioACL™ Technique

The BioACL technique harnesses the power of next-generation biologics to provide the ultimate anatomic, minimally invasive, reproducible approach for taking patient outcomes to the next level.
By prefilling ACL bone tunnels with a powerful composite of concentrated platelet-rich plasma (cPRP) from bone marrow aspirate (BMA) or whole blood processed with the Angel® system, the patient’s own bone collected with the GraftNet™ device, and AlloSync® Pure demineralized bone matrix, the BioACL technique provides all the necessary healing components for an ACL reconstruction procedure.
In conjunction with the QuadLink™ technique with the InternalBrace™ procedure, the BioACL technique has been shown to result in earlier range of motion, improved limb symmetry, less bone-tunnel widening, and improved patient-reported outcomes as compared to nonaugmented ACL procedures.1&nbsp;
 
 
Reference
1. Lavender CD, Schaver AL, Taylor S, et al. Anterior cruciate ligament reconstruction augmentation with bone marrow aspirate concentrate, demineralized bone matrix, and suture tape shows no difference in outcomes—but faster functional recovery—versus non-augmented anterior cruciate ligament reconstruction. Arthroscopy. 2025;41(5):1496-1508. <a href="https://doi.org/10.1016/j.arthro.2024.06.042">https://doi.org/10.1016/j.arthro.2024.06.042</a>
 
The&nbsp;InternalBrace surgical technique is intended only to augment the primary repair/reconstruction by expanding the area of tissue approximation during the healing period and is not intended as a replacement for the native ligament. The&nbsp;InternalBrace technique is for use during soft tissue-to-bone fixation procedures and is not cleared for bone-to-bone fixation.

Cardiothoracic Surgery

Arthrex has comprehensive PRP processing system offerings, with the ACP® double-syringe system, ACP Max™ PRP system, and Angel® system. All provide unique benefits to create a PRP solution that fits within your procedural needs.
<ul>
 <li>ACP double-syringe system: 15 mL of whole blood is collected and centrifuged for 5 minutes resulting in a quick and safe method for PRP collection1</li>
 <li>ACP Max PRP system: 30, 60, or 90 mL of whole blood can be processed, for up to 12x increase in platelet concentration1-3</li>
 <li>Arthrex Angel system: customized PRP formulations with one-touch automation from whole blood or bone marrow apspirate.&nbsp;</li>
</ul>
References&nbsp;
1. Arthrex, Inc. Data on file (APT 5368). Naples, FL; 2021.&nbsp;
2. Arthrex, Inc. Data on file (APT 5535). Naples, FL; 2022.&nbsp;
3. Arthrex, Inc. Data on file (APT-5756). Naples, FL; 2022

Platelet-Rich Plasma (PRP) Processing Systems

The BioSurge™ cell and bone graft processing system combines the matrices of the AlloSync™ bone grafting solutions line with the Angel® system’s proprietary technology to prepare customized platelet-rich plasma concentrate (cPRP) from bone marrow aspirate (BMA). Hydrated AlloSync bone grafts provide the optimal scaffold for cPRP from BMA, which is a rich source of platelets and nucleated and progenitor cells.

Arthrex Angel cPRP & BMA Tray

ABS-10062T

Items in Set (1)

ABS-10063

ABS-10062T is a Set Item Of (4)

ABS-2016-01

ABS-2016-02

ABS-2016-03

ABS-2016-05

Related Pages

Orthobiologics

Angel^® System

Product

Orthobiologics

Angel^® cPRP and Bone Marrow Processing System

Product

Knee

ACL Repair

Procedure

Orthobiologics

BioACL™ Technique

Procedure

Knee

BioACL™ Technique

Procedure

Cardiothoracic Surgery

Platelet-Rich Plasma (PRP) Processing Systems

Product

Orthobiologics

BioSurge™ Cell and Bone Graft Processing System

Product

Knee

BioSurge™ Cell and Bone Graft Processing System

Product